Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

Conjunctivitis represents a relatively frequent AE in patients with AD receiving dupilumab or tralokinumab. However, earlier onset of conjunctivitis with tralokinumab and higher discontinuation rates with dupilumab suggest differing tolerability profiles. Early recognition of ocular symptoms is essential, and dermatologists should promptly initiate supportive eye care and refer to ophthalmologists when appropriate to avoid unnecessary treatment interruptions.

Authors

Institutions

Publication Details

Journal
International Journal of Dermatology
Published
2025-08-20
DOI
https://doi.org/10.1111/ijd.70027
Citations
3
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
6.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

Simone Ribero, Maddalena Napolitano, Laura Calabrese, Flavia Pigliacelli et al.
3 citations
International Journal of Dermatology
Dermatology and Skin Diseases
6.01
article

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

Simone Ribero, Maddalena Napolitano, Laura Calabrese, Flavia Pigliacelli, Maria Esposito, Mariateresa Rossi, Rosanna Satta, Niccolò Gori, Lina Maria Magnanimi, Bianca Maria Piraccini, Carlotta Gurioli, Laura Lazzeri, Giovanni Rubegni, Emiliano Antiga, Luca Stingeni, Ilaria Trave, Ruggero Cascio Ingurgio, Marika Del Gaudio, Mario Bruno Guanti, Paolo ROMITA, Oriele Sarno, Antonio Costanzo, Maria Mariano, Luca Potestio, Maria Concetta Fargnoli, Michela Ortoncelli, Elena Pezzolo, Cataldo Patruno, Monica Corazza, Emanuela Martina, Pietro Morrone, Flavia Manzo Margiotta, Andrea Carugno, Pietro Rubegni, Nicola Zerbinati, Eustachio Nettis, Caterina Foti, Marco Romanelli, Silvia Mariel Ferrucci, Alessandra Narcisi, Laura Bonzano, Francesca Barei, Claudio Marasca, Katharina Hansel, Benedetta Tirone, Ketty Peris, Fabrizio Guarneri, Rosa Valentina Puca, Francesca di Vico, Elena Ippoliti, Laura Grigolato
article en
3 citations

Abstract

Conjunctivitis represents a relatively frequent AE in patients with AD receiving dupilumab or tralokinumab. However, earlier onset of conjunctivitis with tralokinumab and higher discontinuation rates with dupilumab suggest differing tolerability profiles. Early recognition of ocular symptoms is essential, and dermatologists should promptly initiate supportive eye care and refer to ophthalmologists when appropriate to avoid unnecessary treatment interruptions.

International Journal of DermatologyVol. 65(2)
University of Siena (IT), Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Messina (IT), University of Insubria (IT), University of Modena and Reggio Emilia (IT), Marche Polytechnic University (IT), University of Molise (IT), Humanitas University (IT), University of Sassari (IT), Scuola Superiore Sant'Anna (IT), University of Ferrara (IT), University of L'Aquila (IT), University of Perugia (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Azienda Ospedaliera di Cosenza (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Fatebenefratelli Hospital (IT), Azienda Ospedaliera S.Giuseppe Moscati (IT), Ospedale Santa Maria (IT), Azienda USL di Bologna (IT), Azienda Ospedaliera S.Maria (IT), San Gallicano Hospital (IT), Ospedale Policlinico San Martino (IT), University of the Sacred Heart (JP), Ospedale San Bortolo (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Humanitas Research Hospital (IT), University of Florence (IT), University of Turin (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), University of Brescia (IT), University of Bologna (IT)
Università degli Studi di Napoli Federico II, Università Degli Studi di Modena e Reggio Emila, Università degli Studi di Genova, Università di Bologna, Università degli Studi di Torino, Università degli Studi di Brescia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Perugia
Openalex Percentile: Top 4%
Dermatology and Skin Diseases
6.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.